References
- 1. European Medicines Agency: Committee for Medicinal Products for Human Use, Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus, Rev 1, 2012; http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/06/WC500129256.pdf; access date May 25, 2015.
- 2. E. R. Seaquist, J. Anderson, B. Childs, P. Cryer, S. Dagogo-Jack, L. Fish, S. R. Heller, H. Rodriguez, J. Rosenzweig and R. Vigersky, Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and The Endocrine Society Diabetes Care, Diabetes Care36 (2013) 1384–1395; DOI: 10.2337/dc12-2480.
- 3. V. J. Briscoe and S. N. Davis, Hypoglycemia in type 1 and type 2 diabetes: Physiology, Pathophysiology, and Management, Clin. Diabetes24 (2006) 115–121; DOI: 10.2337/diaclin.24.3.115.
- 4. C. Kenny, When hypoglycemia is not obvious: Diagnosing and treating under-recognized and undisclosed hypoglycemia, Prim. Care Diabetes8 (2014) 3–11; DOI: 10.1016/j.pcd.2013.09.002.
- 5. C. Ryan, N. Gurtunca and D. Becker, Hypoglycemia: A complication of diabetes therapy in children, Pediatr. Clin. North Am.52 (2005) 1705–1733.
- 6. A. Franc, J. Muselík, D. Sabadková and D. Neumann, Preparation of pellets with controlled release of glucose as prevention of hypoglycaemia in paediatric patients, Eur. J. Pharm. Sci.75 (2015) 72–80; DOI: 10.1016/j.ejps.2015.03.007.
- 7. European Pharmacopoeia, 8th edition, Council of Europe, Strasbourg 2013.
- 8. M. Rabišková, Technological parameters of drug microforms, their importance and the methods of their determination, Ceska Slov. Farm.45 (1996) 177–179.
- 9. F. Podczeck, S. R. Rahman and J. M. Newton, Evaluation of a standardised procedure to assess the shape of pellets using image analysis, Int. J. Pharm.192 (199) 123–138.
- 10. R. Chopra, F. Podczeck, J. M. Newton and G. Alderborn, The influence of pellet shape and film coating on the filling of pellets into hard shell capsules, Eur. J. Pharm. Biopharm.53 (2002) 327–333.
- 11. C. T. Rhodes and S. C. Porter, Coatings for controlled-release drug delivery systems, Drug Dev. Ind. Pharm.24 (1998) 1139–1154.
- 12. H. U. Petereit and W. Weisbrod, Formulation and process considerations affecting the stability of solid dosage forms formulated with methacrylate copolymers, Eur. J. Pharm. Biopharm.47 (1999) 15–25.
- 13. J. Vertomrnen and R. Kinget, The influence of five selected processing and formulation variables on the particle size, particle size distribution, and friability of pellets produced in a rotary processor, Drug Dev. Ind. Pharm.23 (1997) 39–46.
- 14. J. Muselík, K. Dvořáčková, K. Krejčová, M. Rabišková, J. Pazourek, S. Marton, M. Dráčková and L. Vorlová, Pellet coating thickness determination by near-infrared reflectance spectroscopy: comparison of two reference methods, Curr. Pharm. Anal.6 (2010) 225–233; DOI: 10.2174/157341210793292419.
- 15. L. A. Felton and J. W. McGinity, Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, 3rd edition, CMC Press, Boca Raton 2008.
- 16. F. Sadeghi, J. L. Ford and A. Rajabi-Siahboomi, The influence of drug type on the release profiles from Surelease-coated pellets, Int. J. Pharm.254 (2003) 123–135; DOI: 10.1016/S0378-5173(03)00003-6.
- 17. J. J. Soisa, A. Sousa, M. J. Moira, F. Podczeck and J. M. Newton, The influence of core materials and film coating on the drug release from coated pellets, Int. J. Pharm.233 (2002) 111–122; DOI: 10.1016/S0378-5173(01)00921-8.
- 18. A. Franc, K. Dvořáčková, M. Kejdušová and R. Goněc, Physiological factors with impact on the drug behaviour in the gastrointestinal tract, Ceska Slov. Farm.62 (2013) 243−248.
- 19. S. Milojevic, J. M. Newton, J. H. Cummings, G. R. Gibson, R. L. Botham, S. G. Ring, M. Stockham and M. C. Alwood, Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets, J. Control. Release38 (1996) 85−94; DOI: 10.1016/0168-3659(95)00113-1.
- 20. J. Rojas, S. Guisao and V. Ruge, Functional assessment of four types of disintegrants and their effect on the spironolactone release properties, AAPS PharmSciTech.13 (2012) 1054–1062; DOI: 10.1208/s12249-012-9835-y.
- 21. M. Rabišková, A. Häring, K. Minczingerová, M. Havlásek and P. Musilová, Microcrystalline cellulose in oral dosage forms, Chem. Listy101 (2007) 70−77.
- 22. A. Franc, D. Sabadková, D. Neumann, S. Pavloková, Kopecká and P. J. Muselík, Interdiction of hypoglycemia in diabetic children by multiparticulate dosage form with controlled glucose release, Pharm. Dev. Technol.3 (2015) 1–8.